STOCK TITAN

Centessa Pharmaceuticals Plc (CNTA) Debt by Year

CNTA

Centessa Pharmaceuticals Plc carried $110.1M in long-term debt against $61.3M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 1.1% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Centessa Pharmaceuticals Plc has filed alongside them.

FY2025 annual
Long-Term Debt $110.1M
Cash & Equivalents $61.3M
YoY +1.1%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNTA Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Long-Term Debt$110.1M+1.1%$108.9M+43.9%$75.7M+8.5%$69.8M-7.8%$75.7M$0N/A
Cash & Equivalents$61.3M-84.0%$383.2M+199.3%$128.0M-67.5%$393.6M-33.9%$595.1M+8134.1%$7.2M-56.4%$16.6M

CNTA Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Long-Term Debt$110.4M+1.1%$110.1M+1.1%$109.8M+45.1%$109.5M+43.2%$109.3M+42.3%$108.9M+43.9%$75.7M+2.3%$76.5M+4.4%$76.8M+7.3%$75.7M+8.5%$74.0M+8.5%$73.3M+8.8%
Cash & Equivalents$62.4M-40.6%$61.3M-84.0%$50.8M-87.1%$44.2M-65.3%$105.2M-11.0%$383.2M+199.3%$395.0M+130.3%$127.4M-12.3%$118.2M-54.5%$128.0M-67.5%$171.5M-61.4%$145.2M-70.0%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Centessa Pharmaceuticals Plc financials

Frequently Asked Questions

What was Centessa Pharmaceuticals Plc's long-term debt in fiscal year 2025?

Centessa Pharmaceuticals Plc carried $110.1M in long-term debt against $61.3M in cash and equivalents at the end of fiscal year 2025.

How fast is Centessa Pharmaceuticals Plc's long-term debt growing?

Centessa Pharmaceuticals Plc (CNTA) long-term debt rose by 1.1% year over year, from $108.9M to $110.1M in fiscal year 2025.

What was Centessa Pharmaceuticals Plc's long-term debt in the most recent quarter?

Centessa Pharmaceuticals Plc (CNTA) reported $110.4M in long-term debt in Q1 2026. This represents an increase of 1.1% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Centessa Pharmaceuticals Plc (CNTA) reported on that line in every period on record.